Abstract
The antitrypanosomal drug melarsamine hydrochloride (MelCy) (trade name, Cymelarsan) is a melamino-phenylarsine made by conjugation of one equivalent of melarsen oxide and two equivalents of cysteamine. Immediately after it was dissolved in water, the compound was found to exist as an equilibrium mixture containing MelCy (43%), MelCy which had lost one cysteamine moiety (MelCy -1; 24%), melarsen oxide (33%), and free cysteamine. Small amounts (< 1%) of the oxidation products derived from the last two components were also formed (cystamine and sodium melarsen). On incubation at room temperature, the MelCy content decreased steadily, with an associated increase in the melarsen oxide and sodium melarsen contents. After 5 days in solution at room temperature, 27% of the arsenical agent was MelCy, 14% was MelCy -1, 42% was melarsen oxide, and 17% was sodium melarsen. Since H2O2 production was detectable in MelCy or cysteamine solutions and the addition of small amounts of exogenous H2O2 readily converted the trivalent melarsen oxide to the pentavalent sodium melarsen, it is hypothesized that the nonenzymatic conversion of cysteamine to cystamine produced H2O2, which then oxidized melarsen oxide to sodium melarsen. Similar time course experiments showed that melarsonyl potassium and melarsoprol were more stable in solution.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Carter N. S., Fairlamb A. H. Arsenical-resistant trypanosomes lack an unusual adenosine transporter. Nature. 1993 Jan 14;361(6408):173–176. doi: 10.1038/361173a0. [DOI] [PubMed] [Google Scholar]
- Fairlamb A. H., Carter N. S., Cunningham M., Smith K. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Mol Biochem Parasitol. 1992 Jul;53(1-2):213–222. doi: 10.1016/0166-6851(92)90023-d. [DOI] [PubMed] [Google Scholar]
- Fairlamb A. H., Henderson G. B., Cerami A. Trypanothione is the primary target for arsenical drugs against African trypanosomes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2607–2611. doi: 10.1073/pnas.86.8.2607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Jennings F. W. Chemotherapy of CNS-trypanosomiasis: combination chemotherapy with a 5-nitroimidazole (MK 436), an arsenical (Cymelarsan) and suramin. Trop Med Parasitol. 1991 Sep;42(3):157–160. [PubMed] [Google Scholar]
- Jennings F. W. Relative efficacy of melarsen oxide compared with mel Cy (Cymelarsan) when used in combination with difluoromethylornithine in the treatment of trypanosomiasis of the central nervous system. Trans R Soc Trop Med Hyg. 1992 May-Jun;86(3):257–258. doi: 10.1016/0035-9203(92)90300-2. [DOI] [PubMed] [Google Scholar]
- Lun Z. R., Min Z. P., Huang D., Liang J. X., Yang X. F., Huang Y. T. Cymelarsan in the treatment of buffaloes naturally infected with Trypanosoma evansi in south China. Acta Trop. 1991 Aug;49(3):233–236. doi: 10.1016/0001-706x(91)90042-i. [DOI] [PubMed] [Google Scholar]
- Otsyula M., Kamar K., Mutugi M., Njogu A. R. Preliminary efficacy trial of Cymelarsan, a novel trypanocide, in camels naturally infected with Trypanosoma evansi in Kenya. Acta Trop. 1992 Feb;50(3):271–273. doi: 10.1016/0001-706x(92)90084-b. [DOI] [PubMed] [Google Scholar]
- Pepin J., Milord F. African trypanosomiasis and drug-induced encephalopathy: risk factors and pathogenesis. Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):222–224. doi: 10.1016/0035-9203(91)90032-t. [DOI] [PubMed] [Google Scholar]
- Pick E., Keisari Y. A simple colorimetric method for the measurement of hydrogen peroxide produced by cells in culture. J Immunol Methods. 1980;38(1-2):161–170. doi: 10.1016/0022-1759(80)90340-3. [DOI] [PubMed] [Google Scholar]
- Zhang Z. Q., Giroud C., Baltz T. In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium. Acta Trop. 1991 Dec;50(2):101–110. doi: 10.1016/0001-706x(91)90002-2. [DOI] [PubMed] [Google Scholar]
- Zweygarth E., Kaminsky R. Evaluation of an arsenical compound (RM 110, mel Cy, Cymelarsan) against susceptible and drug-resistant Trypanosoma brucei brucei and T.b. evansi. Trop Med Parasitol. 1990 Jun;41(2):208–212. [PubMed] [Google Scholar]
- Zweygarth E., Ngeranwa J., Kaminsky R. Preliminary observations on the efficacy of mel Cy (Cymelarsan) in domestic animals infected with stocks of Trypanosoma brucei brucei and T.b. evansi. Trop Med Parasitol. 1992 Dec;43(4):226–228. [PubMed] [Google Scholar]